Direxion Daily Pharmaceutical & Medical Bull 3X Shares Rating $7.31 +0.13 (+1.81%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatings Direxion Daily Pharmaceutical & Medical Bull 3X Shares Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PILL Aggregate RatingModerate Buy 2.69Holdings in PILL have an aggregate rating of Moderate Buy based on 362 analyst ratings issued in the past year covering 44 companies (77.8% of the portfolio).PILL Aggregate Price Target$7.31High Prediction$7.31Average Prediction$7.31Low Prediction$7.31Holdings in PILL have an aggregate price target of $7.31 and a range of $7.31 to $7.31 covering 44 companies (77.8% of the portfolio).PILL Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy17 Buy rating(s)Moderate Buy20 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Direxion Daily Pharmaceutical & Medical Bull 3X Shares Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 44 PILL Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.27%CORTCorcept Therapeutics$51.40+0.5%4.851 of 5 stars3.00$65.25 26.9%5Analyst RevisionHigh Trading Volume3.38%JAZZJazz Pharmaceuticals$122.97+0.1%4.8615 of 5 stars2.87$177.00 43.9%15High Trading Volume3.33%BMYBristol-Myers Squibb$57.33+1.8%4.7851 of 5 stars2.25$55.64 -2.9%20High Trading Volume3.31%ITCIIntra-Cellular Therapies$83.45-0.8%4.0543 of 5 stars2.85$97.23 16.5%133.15%VTRSViatris$12.52+3.2%1.8728 of 5 stars2.00$13.67 9.2%3News CoverageHigh Trading Volume3.12%CTLTCatalent$63.482.7663 of 5 stars2.00$63.40 -0.1%72.89%EWTXEdgewise Therapeutics$30.78-0.1%2.7186 of 5 stars3.00$43.17 40.2%6Analyst ForecastAnalyst Revision2.82%PRGOPerrigo$25.75+0.1%4.9874 of 5 stars2.75$37.00 43.7%4Positive News2.81%AXSMAxsome Therapeutics$90.73+1.1%4.769 of 5 stars3.00$125.93 38.8%14Positive News2.70%ZTSZoetis$164.84+0.8%4.5863 of 5 stars3.09$215.22 30.6%11High Trading Volume2.65%TARSTarsus Pharmaceuticals$52.91+1.8%0.3891 of 5 stars3.00$54.20 2.4%7Positive News2.64%RPRXRoyalty Pharma$24.92+2.6%4.5849 of 5 stars2.83$41.67 67.2%6High Trading Volume2.55%JNJJohnson & Johnson$144.47+0.6%4.8599 of 5 stars2.50$174.73 20.9%14High Trading Volume2.53%PFEPfizer$26.36+2.3%4.9704 of 5 stars2.47$32.14 21.9%17Analyst ForecastOptions VolumeAnalyst RevisionHigh Trading Volume2.53%MRKMerck & Co., Inc.$98.05-1.5%4.9889 of 5 stars2.71$127.13 29.7%21Analyst DowngradeHigh Trading Volume2.48%LLYEli Lilly and Company$767.76+1.3%4.9941 of 5 stars2.81$1,002.22 30.5%21Gap UpHigh Trading Volume2.46%ELANElanco Animal Health$11.63-1.6%3.7822 of 5 stars2.25$16.71 43.7%82.10%PBHPrestige Consumer Healthcare$78.72+0.1%3.7945 of 5 stars2.50$85.25 8.3%4Analyst UpgradePositive NewsHigh Trading Volume2.09%OGNOrganon & Co.$14.58+1.0%4.8039 of 5 stars2.50$21.33 46.3%4High Trading Volume1.97%PCRXPacira BioSciences$18.98-3.0%3.7482 of 5 stars2.20$23.50 23.8%10Gap DownHigh Trading Volume1.85%SUPNSupernus Pharmaceuticals$35.43-1.0%2.1946 of 5 stars2.50$36.00 1.6%2High Trading Volume1.64%ARVNArvinas$18.48+3.6%2.0251 of 5 stars2.93$63.50 243.6%15High Trading Volume1.59%LGNDLigand Pharmaceuticals$114.64+0.6%4.9822 of 5 stars3.00$147.00 28.2%6Analyst RevisionHigh Trading Volume1.56%AMPHAmphastar Pharmaceuticals$39.14-0.6%4.8626 of 5 stars2.50$60.33 54.1%4High Trading Volume1.28%COLLCollegium Pharmaceutical$29.70-2.4%3.946 of 5 stars2.60$42.60 43.4%5News CoveragePositive NewsHigh Trading Volume1.26%ANIPANI Pharmaceuticals$53.35-1.7%4.8429 of 5 stars3.00$77.71 45.7%8Insider TradeHigh Trading Volume1.11%OCULOcular Therapeutix$8.50+0.6%3.6483 of 5 stars2.86$16.71 96.6%7News CoveragePositive News1.04%HRMYHarmony Biosciences$34.28+1.2%4.7853 of 5 stars2.60$49.80 45.3%10Analyst ForecastAnalyst RevisionHigh Trading Volume0.98%AMRXAmneal Pharmaceuticals$7.78+0.4%3.0374 of 5 stars2.80$10.00 28.5%5Analyst DowngradeNews Coverage0.96%FULCFulcrum Therapeutics$4.35+7.9%1.7128 of 5 stars2.20$9.33 114.6%10Positive NewsHigh Trading Volume0.92%MNMDMind Medicine (MindMed)$7.16+2.1%2.9363 of 5 stars3.25$26.75 273.6%12Analyst ForecastNews Coverage0.89%WVEWave Life Sciences$13.51+2.4%4.8801 of 5 stars3.00$22.22 64.5%9High Trading Volume0.85%HROWHarrow$34.22-0.6%2.389 of 5 stars3.00$63.00 84.1%3Positive News0.83%LQDALiquidia$11.10+4.8%3.2803 of 5 stars3.11$25.38 128.6%9Analyst ForecastNews CoverageHigh Trading Volume0.80%INVAInnoviva$17.84-0.5%2.0043 of 5 stars3.001Positive NewsHigh Trading Volume0.79%PLRXPliant Therapeutics$13.21-0.7%3.3664 of 5 stars3.13$40.50 206.6%8High Trading Volume0.64%NMRANeumora Therapeutics$10.85+3.3%2.4718 of 5 stars2.83$23.40 115.7%6Analyst RevisionGap DownHigh Trading Volume0.58%EYPTEyePoint Pharmaceuticals$7.10-0.3%1.9266 of 5 stars3.00$25.71 262.2%9News CoverageGap DownHigh Trading Volume0.52%ELVNEnliven Therapeutics$22.47-1.7%2.7826 of 5 stars3.20$38.25 70.2%5Positive News0.48%NUVBNuvation Bio$2.68-0.4%2.3873 of 5 stars3.00$6.60 146.3%5News CoverageGap DownHigh Trading Volume0.43%EOLSEvolus$10.89+0.2%3.8214 of 5 stars3.00$23.00 111.2%40.43%XERSXeris Biopharma$3.49+2.3%3.6058 of 5 stars2.67$4.87 39.4%3News CoveragePositive News0.37%PHATPhathom Pharmaceuticals$7.45-4.7%2.9846 of 5 stars2.75$23.00 208.7%4High Trading Volume0.22%SAVACassava Sciences$2.35+2.6%4.4043 of 5 stars2.50$111.50 4,644.7%2News CoverageGap Down This page (NYSEARCA:PILL) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily Pharmaceutical & Medical Bull 3X Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily Pharmaceutical & Medical Bull 3X Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PILL Stock Alerts